Literature DB >> 21757673

The montreal cognitive assessment: short cognitive evaluation in a large stroke trial.

Toby B Cumming1, Julie Bernhardt, Thomas Linden.   

Abstract

BACKGROUND AND
PURPOSE: Cognitive function is often ignored in stroke research trials. The brief Montreal Cognitive Assessment (MoCA) may be sensitive to stroke-related cognitive deficits.
METHODS: We evaluated the feasibility of administering the MoCA at 3 months in a large stroke trial (A Very Early Rehabilitation Trial [AVERT]).
RESULTS: Data (blinded to intervention group) are presented for 294 patients with mean age of 70.6 years (SD, 12.8); 220 (75%) completed the MoCA, 54 (18%) had missing data, and 20 (7%) had died. Of those surviving to 3 months, the MoCA was completed by 87% with mild stroke, 79% with moderate stroke, and 67% with severe stroke on admission. Mean MoCA score was 21.1 (SD 7.5) out of 30; only 78 of 220 (35%) patients attained the "normal" cutoff (≥26).
CONCLUSIONS: The MoCA is a feasible global cognitive screening tool in stroke trials. Clinical Trial Registration- URL: www.anzctr.org.au/trial_view.aspx?ID=1266. Unique identifier: ACTRN12606000185561.

Entities:  

Mesh:

Year:  2011        PMID: 21757673     DOI: 10.1161/STROKEAHA.111.619486

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

Review 1.  Spatial cognitive rehabilitation and motor recovery after stroke.

Authors:  A M Barrett; Tufail Muzaffar
Journal:  Curr Opin Neurol       Date:  2014-12       Impact factor: 5.710

2.  Assessing and treating forgetfulness and cognitive problems in adults with HIV.

Authors:  David E Vance; Pariya L Fazeli; Linda Moneyham; Norman L Keltner; James L Raper
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

3.  Author's reply to Page: "Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept".

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

4.  The Unfolding of Cognitive Effort During Sentence Processing: Pupillometric Evidence From People With and Without Aphasia.

Authors:  Laura Roche Chapman; Brooke Hallowell
Journal:  J Speech Lang Hear Res       Date:  2021-11-11       Impact factor: 2.674

5.  Normative Data for the Montreal Cognitive Assessment in Middle-Aged and Elderly Quebec-French People.

Authors:  Eddy Larouche; Marie-Pier Tremblay; Olivier Potvin; Sophie Laforest; David Bergeron; Robert Laforce; Laura Monetta; Linda Boucher; Pascale Tremblay; Sylvie Belleville; Dominique Lorrain; Jean-François Gagnon; Nadia Gosselin; Christian-Alexandre Castellano; Stephen C Cunnane; Joël Macoir; Carol Hudon
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

6.  Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.

Authors:  Emilia Salvadori; Marco Pasi; Anna Poggesi; Guido Chiti; Domenico Inzitari; Leonardo Pantoni
Journal:  J Neurol       Date:  2013-05-29       Impact factor: 4.849

7.  Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.

Authors:  Edward Tobinick; Nancy M Kim; Gary Reyzin; Helen Rodriguez-Romanacce; Venita DePuy
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

8.  Very early versus delayed mobilisation after stroke.

Authors:  Peter Langhorne; Janice M Collier; Patricia J Bate; Matthew Nt Thuy; Julie Bernhardt
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16

9.  Comparison of montreal cognitive assessment and mini-mental state examination in evaluating cognitive domain deficit following aneurysmal subarachnoid haemorrhage.

Authors:  George Kwok Chu Wong; Sandy Wai Lam; Adrian Wong; Karine Ngai; Wai Sang Poon; Vincent Mok
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

10.  A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design.

Authors:  Alla Guekht; Ingmar Skoog; Amos D Korczyn; Vladimir Zakharov; Martin Eeg; Ulf Vigonius
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.